9th European AIDS Conference (EACS), 25-29 October 2003, Warsaw
1 December 2003. Related: Conference reports.
EACS 9th Warsaw 2003
Lower doses of d4T produce similar efficacy and reduced side effects
1 December 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Interruption of treatment is safe for those who started too early
1 December 2003. Related: Conference reports, Treatment strategies.
T20 is cost effective for UK purchasers
1 December 2003. Related: Conference reports, Antiretrovirals.
Intrauterine exposure to efavirenz
1 December 2003. Related: Conference reports, Women's health, Pregnancy, Side effects.
Five-year results of Kaletra-based therapy in treatment-naïve HIV patients
1 December 2003. Related: Conference reports, Antiretrovirals.
IL-2 effectively increases CD4 count in people with low CD4 nadir
1 December 2003. Related: Conference reports, Basic science and immunology.
Hepatitis coinfection: incidence in Europe and response to transplant
1 December 2003. Related: Conference reports, Hepatitis coinfection.
Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)
1 December 2003. Related: Conference reports, Antiretrovirals, Cancer and HIV.